Upon return of the signed informed consent form, we will enroll the woman in the study and randomize her to receive either the study intervention or standard care. We will ensure balance in this process through the use of block randomization. At this time point, our research assistant will assist with scheduling the woman's 6-week postpartum follow-up visit, which is a part of her standard medical care. This assistance with scheduling, will aid in making sure that the potential study participant receives her 6-week postpartum diabetes screening. If she fails the screening, then she will be notified by a study clinician and withdrawn from the study.